Ina Fried Sep 26
SaveSave story
Apple, Fitbit and Samsung part of FDA trial aimed at speeding tech development
AP file photo

Some of the biggest names in tech and health care are taking part in a pilot program from the FDA that looks to make it easier for companies looking to offer technology approaches to issues that fall under the agency's purview.

Why it matters: A lot of tech companies have been focusing on relatively modest products in the "wellness" space rather than more ambitious efforts that require cumbersome and time-consuming regulatory approval.